Samsung Epis Holdings Reports Q3 Revenue of KRW 441.9B, Operating Profit of KRW 105.0B
Samsung Bioepis reported Q3 revenue of KRW 442.2B and operating profit of KRW 132.6B. Its nine-month operating profit was KRW 363.2B, equal to 97% of FY25.
Samsung Epis Holdings reported Q3 2026 consolidated revenue of KRW 441.9B and operating profit of KRW 105.0B. Subsidiary Samsung Bioepis posted Q3 revenue KRW 442.2B and operating profit KRW 132.6B, with 9M operating profit at KRW 363.2B (97% of FY25).Material DetailsContext by AI AnalystThis is a…